These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Cutaneous-malignancy and leprosy. Report of a patient with Mycobacterium leprae and basal cell carcinoma concurrently present in the same lesion. Ratoosh SL; Cohen PR; Troncoso P J Dermatol Surg Oncol; 1994 Sep; 20(9):613-8. PubMed ID: 8089361 [TBL] [Abstract][Full Text] [Related]
44. CD2 expression and function in lepromatous leprosy. Wong L; Salgame P; Torigian VK; Fu TH; Rea TH; Modlin RL Infect Immun; 1989 Sep; 57(9):2815-9. PubMed ID: 2474503 [TBL] [Abstract][Full Text] [Related]
46. Histopathologic evidence to show that indeterminate leprosy may be a primary lesion of the disease. Job CK; Baskaran B; Jayakumar J; Aschhoff M Int J Lepr Other Mycobact Dis; 1997 Dec; 65(4):443-9. PubMed ID: 9465152 [TBL] [Abstract][Full Text] [Related]
48. Expression of costimulatory molecules (CD80, CD86, CD28, CD152), accessory molecules (TCR alphabeta, TCR gammadelta) and T cell lineage molecules (CD4+, CD8+) in PBMC of leprosy patients using Mycobacterium leprae antigen (MLCWA) with murabutide and T cell peptide of Trat protein. Sridevi K; Neena K; Chitralekha KT; Arif AK; Tomar D; Rao DN Int Immunopharmacol; 2004 Jan; 4(1):1-14. PubMed ID: 14975355 [TBL] [Abstract][Full Text] [Related]
49. Immunosuppressive roles for IL-10 and IL-4 in human infection. In vitro modulation of T cell responses in leprosy. Sieling PA; Abrams JS; Yamamura M; Salgame P; Bloom BR; Rea TH; Modlin RL J Immunol; 1993 Jun; 150(12):5501-10. PubMed ID: 8515073 [TBL] [Abstract][Full Text] [Related]
50. Interleukin-1 beta production by monocytes from leprosy patients. Choi IH; Shin JS; Park SK; Cho SN; Kim JD; Kim SJ Yonsei Med J; 1990 Dec; 31(4):301-7. PubMed ID: 2077754 [TBL] [Abstract][Full Text] [Related]
51. Restoration of defective cytokine activity within lepromatous leprosy lesions. Volc-Platzer B; Kremsner P; Stemberger H; Wiedermann G Zentralbl Bakteriol; 1990 Apr; 272(4):458-66. PubMed ID: 1972881 [TBL] [Abstract][Full Text] [Related]
52. Learning from lesions: patterns of tissue inflammation in leprosy. Modlin RL; Melancon-Kaplan J; Young SM; Pirmez C; Kino H; Convit J; Rea TH; Bloom BR Proc Natl Acad Sci U S A; 1988 Feb; 85(4):1213-7. PubMed ID: 3257577 [TBL] [Abstract][Full Text] [Related]
53. Differential interferon- gamma production characterizes the cytokine responses to Leishmania and Mycobacterium leprae antigens in concomitant mucocutaneous leishmaniasis and lepromatous leprosy. Matos DS; Azeredo-Coutinho RB; Schubach A; Conceição-Silva F; Baptista C; Moreira JS; Mendonça SC Clin Infect Dis; 2005 Jan; 40(2):e5-12. PubMed ID: 15655736 [TBL] [Abstract][Full Text] [Related]
54. Genetically restricted suppressor T-cell clones derived from lepromatous leprosy lesions. Modlin RL; Kato H; Mehra V; Nelson EE; Fan XD; Rea TH; Pattengale PK; Bloom BR Nature; 1986 Jul 31-Aug 6; 322(6078):459-61. PubMed ID: 2942780 [TBL] [Abstract][Full Text] [Related]
55. Reversal of T cell anergy in leprosy patients: in vitro presentation with Mycobacterium leprae antigens using murabutide and Trat peptide in liposomal delivery. Sridevi K; Khanna N; Chattree V; Pal PC; Haq W; Rao DN Int Immunopharmacol; 2003 Nov; 3(12):1589-600. PubMed ID: 14555284 [TBL] [Abstract][Full Text] [Related]
56. Mycobacterium leprae-Infected Macrophages Preferentially Primed Regulatory T Cell Responses and Was Associated with Lepromatous Leprosy. Yang D; Shui T; Miranda JW; Gilson DJ; Song Z; Chen J; Shi C; Zhu J; Yang J; Jing Z PLoS Negl Trop Dis; 2016 Jan; 10(1):e0004335. PubMed ID: 26751388 [TBL] [Abstract][Full Text] [Related]
57. Lymphocyte proliferation, IFN-gamma production and limiting dilution analysis of T-cell responses to ICRC and Mycobacterium leprae antigens in leprosy patients. Shinde SR; Chiplunkar SV; Butlin R; Samson PD; Deo MG; Gangal SG Int J Lepr Other Mycobact Dis; 1993 Mar; 61(1):51-8. PubMed ID: 8326181 [TBL] [Abstract][Full Text] [Related]
59. Inside the skin: the local immune and inflammatory milieu in leprosy. Scollard DM Am J Trop Med Hyg; 1991 Apr; 44(4 Pt 2):17-23. PubMed ID: 2042708 [TBL] [Abstract][Full Text] [Related]
60. The role of rIL-2 in the modulation of cellular immunity in resistance to infection. Kaplan G Immunol Lett; 1991 Oct; 30(2):199-200. PubMed ID: 1757105 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]